 isradipin daili lower blood pressur object studi effect isradipin placebo blood pressur BP end dose interv three-week placebo period patient respons treatment isradipin offic BP measur treatment mg isradipin week patient studi double-blind phase advers event isradipin placebo blood pressur double-blind studi drug administr valu rate normal diastol BP dbp equal mm Hg isradipine-tr group placebo group patient isradipin fall dbp equal mm Hg dbp mm Hg patient placebo differ signific isradipin dose mg daili lower blood pressur